News

Chronic ocular diseases and ocular surface diseases alike now have new treatment options.

“Remarkable” results were reportedly obtained with hypotony with hydroxypropyl methylcellulose.

Susan Gromacki, OD, MS, FAAO, FSLS, details her presentation given at this year's conference.

Jamie Kuzniar, OD, FAAO, FSLS, details a poster presentation that served as a follow-up to results of previous fittings of Zenlens Chroma HOA (Bausch + Lomb).

Jason Jedlicka, OD, overviews his poster, “A Custom Wavefront-Guided Scleral Lens System For Higher Order Aberrations: Real-World Early Experience From a Retrospective Multicenter Case Review.”

New clinical data and trial updates closed out 2025.

A unique case study of HZO featuring Steve Silberberg, OD, DipABO, as the patient.

The lens was developed in collaboration with Brien Holden Vision Institute (BHVI).

Kramer, OD, FAAO, FSLS, presented alongside Kelsea Skidmore, OD, MS; Vivien Tse, OD; and Elaine Chen, OD, at this year's conference.

Utilize oral agents, diet, and glucose monitoring systems when acting to preserve vision.

Edward Choy, partner at Sho Eyeworks, shares success stories of private practices creating their own eyewear frame line.

Knowing what’s on the market for AMD and GA aids in preserving vision.

Evolutions in AI, myopia management, and individualized care are on ODs' minds for the new year.

The FDA issued a CRL for ONS-5010, citing the need for additional confirmatory efficacy evidence despite previous trials showing efficacy, according to the company.

Edward Choy, partner at Sho Eyeworks, advises practice owners on the fence of developing their own brand to dive in.

Telomere biology may link ocular aging and tissue dysfunction in the eye.

A recent study represents a step forward in investigations of the retinal layers as they are affected by glaucoma.

Edward Choy, partner at Sho Eyeworks, and Diana Canto-Sims, OD, discuss the company's price points and partner subscription options.

New drugs on the market and survey findings were among some of the top stories in dry eye from the past year.

Understanding the different expectations between patients with these conditions is key to choosing the appropriate refractive surgery.

An overview of the top 10 stories from eye care for 2025.

The researchers conducted a literature search of MEDLINE and Embase, PubMed, Cochrane Library, and Web of Sciences databases from 2003 to 2023.

Edward Choy, partner at Sho Eyeworks, and Diana Canto-Sims, OD, drive home the importance of profitability in creating an eyewear brand.

The PDUFA target action date is June 30, 2026.

Justin Schweitzer, OD, outlines the intricacies of glaucoma care with 3 cases.

The study evaluated thermal dynamics associated with CW-TSCPC and TLT using MicroPulse technology, such as temperature peak, exposure duration, and thermal spread in a simulated ciliary body using computer modeling.

The organization reaffirmed that it stands by myopia defined as a chronic, progression disease.

NCX 470 is Nicox’s lead dual-mechanism bimatoprost eye drop for lowering IOP in open-angle glaucoma or ocular hypertension.